Latest filing published 28 Feb 2014 for Travere Therapeutics, Inc..
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- +89.1%Entry US$6.50 · Close at T+365 US$12.29
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Marc L. Panoff: trading record in brief
This profile gathers the share dealings of Marc L. Panoff across 2 companies, led by Travere Therapeutics, Inc. and Neurologix Inc/de. Over a trading history stretching from 30 November 2006 to 24 February 2014, the count stands at 3 filings.
Every open-market trade on record is a purchase: 2 purchases worth €9,367, and no sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 1 share grant.
The newest entry dates from 28 February 2014: a share grant, in Travere Therapeutics, Inc. The most recent open-market purchase was published on 20 August 2013, 4,829 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Marc L. Panoff
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 100,000 shares0Common StockSEC:0001193805-14-000382:0
- 1,100 shares@ US$4.50Common StockSEC:0001193805-13-001504:0Canonical exit: 13 Nov 2013 (T+90)
- 10,000 shares@ US$0.75Common StockSEC:0001304340-06-000004:0Canonical exit: 28 Feb 2007 (T+90)
3 of 3 declarations
